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F A C U L T Y   O F   H E A L T H   A N D   M E D I C A L   S C I E N C E S
U N I V E R S I T Y   O F  C O P E N H A G E N
Effects of artemisinin and Artemisia annua 
extracts on xenic bacteria isolated from clonal 
cultures of Histomonas meleagridis.
Conclusion
• No antibacterial effect was noticed with compound concentrations identical to the antihistomonal 
screening.  
• Since no antibacterial effects were observed on the bacteria isolated from the xenic flora of six 
clonal H. meleagridis cultures the observed inhibition of histomonal multiplication is regarded as 
directly antihistomonal.
• The potential of these materials on histomonosis was subsequently tested in vivo in chickens and 
in turkeys without success.
Background
Infection with the protozoa Histomonas meleagridis in poultry has re-emerged since the ban of effective drugs 
(7). Consequently efforts are set to find alternatives to chemotherapeutics to combat histomonosis. At present 
histomonads need accompanying bacteria when cultured in vitro, probably serving nutrient supply due to 
their appearance in parasitic food vacuoles. However, the relationship of the parasite and the bacteria is not 
fully clear. 
Six previously established clonal cultures of H. meleagridis (5) were used to evaluate the effect of five 
Artemisia annua derived materials (i.e. dry leaves, artemisinin; and hexane, dichloromethane or methanol 
extracts). Dry leaves, artemisinin, hexane and dichloromethane extract displayed significant dose dependant 
inhibitory activity against all six mono-eukaryotic cultures (Figure 1). 
Aim
The aim was to assess whether the observed inhibitory effects on H. meleagridis multiplication could be 
accounted as direct or indirect. 
Methodology
Artemisia annua compounds.
• Dry leaves from Artemisia annua, artemisinin (purity >99%), crude essential oil fractions from A. annua
leaves (Ext-oil-HEX; Ext-oil-DCM; and Ext-oil-MeOH), made using hexane, dichloromethane or methanol 
as extraction methods. 
Isolation and sensitivity testing of xenic bacteria. 
• Bacteria present in the same mono-eukaryotic Histomonas cultures as in the antiprotozoal setting were 
isolated using selective media and biochemical characterisation methods. 
• The antibacterial activity was assessed using the disc diffusion method (1;2). Preparation of inoculum 
followed the CLSI Direct Colony Suspension Method (2). 
• A volume of 20 µl of the test solutions in concentrations identical to those in the antiprotozoal assay were 
loaded onto empty Sensi-discs. Negative controls were loaded with 20 µl PBS and positive controls 
contained 10 µg. 
Discussion
The present susceptibility testing at compound concentrations as used in the antihistomonal setup revealed 
no inhibitory effect on bacterial growth when treated with dried A. annua leaves, artemisinin or either of three 
extractions. 
It is known that artemether, a derivative of artemisinin, has no antibacterial effect on human hospital strains of 
E. coli and S. aureus (4). Similar investigations found that artemisinin had no antibacterial effect on S. aureus 
(3;9). However, artemisinin showed antibacterial properties at 1 mg/ml against E. coli, E. coli NCTC 9002 and 
Proteus vulgaris (3). In our study, the amount of artemisinin loaded onto the discs ranged between 100-300 
µg/disc (20 µl of each test solution per disc) which had no antibacterial effect on the bacterial strains isolated 
from the clonal histomonal cultures. This is in agreement with a study where no antibacterial effect of 100 
µg/disc artemisinin was found on E. coli or S. aureus (8).
To the best of our knowledge, only a single study has addressed the antibacterial effect of essential oil 
components extracted from A. annua (6) in which no inhibitory effect on E. coli and S. aureus was shown, 
whereas complete inhibition was obtained for Enterococcus hirae at 0.1 mg/ml. 
Combining the results of the antiprotozoal screening with the antibacterial tests, it is reasonable to assume 
that the observed inhibitory effect of dried A. annua leaves, artemisinin, Ext-HEX and Ext-DCM, is attributed 
to a direct effect on histomonads and could be regarded as antihistomonal. 
Ext-DCM and artemisinin were found to have the strongest antihistomonal effect in the in vitro studies and 
were therefore selected for further in vivo testing. Despite promising in vitro properties no effect on 
experimental H. meleagridis infection could be demonstrated. 
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Figure1: In vitro responses of Histomonas meleagridis clone 6b to Artemisia annua dry leaves, 
artemisinin; and hexane, dichloromethane or methanol extracts of Artemisia annua
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Discoveries
• In total 19 bacterial strains were isolated from the six mono-eukaryotic H. meleagridis cultures. E. coli 
(8/19) was isolated at least once from all six H. meleagridis cultures, including four APEC isolates (O1, O2, 
or O78). Streptococcus spp. (5/19) or Proteus spp. (5/19) were isolated from four protozoal cultures. 
Staphylococcus sp. was isolated once.
• No inhibitory effect of any of the compounds (dry plant; artemisinin; Ext-oil-HEX; Ext-oil-DCM; and Ext-oil-
MeOH) was observed in any of the 19 isolated bacterial strains from any of the six investigated histomonal 
clones (see example on Figure 2) .
Cloned cultures Bacterial isolates
Histomonas meleagridis/Turkey/Austria/2922-C6/04 Streptococcus sp
E. coli O1, mucoid
E. coli, mucoid
Histomonas meleagridis/Chicken/ Hungary/5009-C2/05 Proteus sp
E. coli, mucoid
Histomonas meleagridis/Turkey/Austria/5642-C4/05 Proteus sp
Proteus sp
E. coli O2, mucoid
Streptococcus sp
Histomonas meleagridis/Chicken/Austria/8175-C7/06 Streptococcus sp
Streptococcus sp, Haem.
E. coli O78, mucoid
Histomonas meleagridis/Turkey/Austria/2877-C3/05  Streptococcus sp
Proteus sp
E. coli O2, mucoid
Histomonas meleagridis/Turkey/Germany/4114-C18/05 Proteus sp
E. coli, mucoid
E. coli
Staphylococcus sp
Table 1. Bacteria isolated from the different cloned cultures of H. meleagridis.
Figure2: Inhibition zones of mucoid E. coli O78 
